roluperidone

Minerva schizophrenia drug rejected by FDA
BioPharma Dive
Tue, 02/27/24 - 11:17 pm
Minerva
schizophrenia
FDA
roluperidone
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
Minerva Shares Plunge After FDA Rejects Schizophrenia Drug Candidate
BioSpace
Tue, 10/18/22 - 11:00 am
Minerva Neurosciences
schizophrenia
FDA
roluperidone
Minerva stumbles with U.S. application for schizophrenia med; shares down 15%
Seeking Alpha
Tue, 12/1/20 - 11:10 am
Minerva Neurosciences
schizophrenia
FDA
roluperidone